Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Dihydropyridine >  Imidazo[1,5-a]pyridin-8(5H)-one, 6,7-dihydro- (9CI)

Imidazo[1,5-a]pyridin-8(5H)-one, 6,7-dihydro- (9CI)

Basic information Safety Supplier Related

Imidazo[1,5-a]pyridin-8(5H)-one, 6,7-dihydro- (9CI) Basic information

Product Name:
Imidazo[1,5-a]pyridin-8(5H)-one, 6,7-dihydro- (9CI)
Synonyms:
  • Imidazo[1,5-a]pyridin-8(5H)-one, 6,7-dihydro- (9CI)
  • Imidazo[1,5-a]pyridin-8(5H)-one,6,7-dihydro-
  • 6,7-Dihydro-5H-imidazo[1,5-a]pyridin-8-one
  • 6,7-Dihydroimidazo[1,5-a]pyridin-8(5H)-one
  • Imidazo[1,5-a]pyridin-8(5H)-one, 6,7-dihydro- (9CI) ISO 9001:2015 REACH
CAS:
426219-51-4
MF:
C7H8N2O
MW:
136.15
Product Categories:
  • AMINETERTIARY
Mol File:
426219-51-4.mol
More
Less

Imidazo[1,5-a]pyridin-8(5H)-one, 6,7-dihydro- (9CI) Chemical Properties

Boiling point:
357.0±11.0 °C(Predicted)
Density 
1.35±0.1 g/cm3(Predicted)
storage temp. 
2-8°C
pka
4.14±0.20(Predicted)
More
Less

Imidazo[1,5-a]pyridin-8(5H)-one, 6,7-dihydro- (9CI) Usage And Synthesis

Synthesis

38666-30-7

426219-51-4

General procedure for the synthesis of 6,7-dihydroimidazo(1,5-a)pyridin-8(5H)-one from 5,6,7,8-tetrahydroimidazo[1,5-a]pyridine: 0.819 mmol of 5,6,7,8-tetrahydroimidazo[1,5-a]pyridine was dissolved in 3 mL of acetonitrile, and 2.457 mmol of potassium permanganate was added, and the reaction was carried out with vigorous stirring for 16 hours at room temperature. for 16 hours at room temperature with vigorous stirring. After completion of the reaction, the acetonitrile was completely removed by rotary evaporation. The residue was dissolved in 15 mL of 0.1 M HCl aqueous solution and kept in an ultrasonic bath at over 50 °C for 2 min. The resulting brown suspension was filtered and the filter cake was washed with 5 mL of 0.1 M HCl aqueous solution. The yellow filtrates were combined, alkalized with 2 M aqueous NaOH and extracted with dichloromethane (3 x 25 mL). The organic phases were combined, dried over sodium sulfate and concentrated by evaporation. From the residue, 0.617 mmol (75% crude yield) of 6,7-dihydroimidazo(1,5-a)pyridin-8(5H)-one was obtained as a yellow oil product. The purity of the crude product was 90% by NMR analysis. The properties of the product are consistent with the material already disclosed in WO 2002/040484.

References

[1] Patent: WO2007/113235, 2007, A1. Location in patent: Page/Page column 18-19
[2] Patent: US2009/118512, 2009, A1. Location in patent: Page/Page column 8

Imidazo[1,5-a]pyridin-8(5H)-one, 6,7-dihydro- (9CI)Supplier

Shanghai Ennopharm Co., Ltd.
Tel
+86 (21) 6435-5022
China Langchem Inc.
Tel
0086-21-58956006
Wisdom Pharmaceutical Co., Ltd.
Tel
0086-15189180296
Email
l_xu@wisdompharma.com
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-66028182 18626450290
Email
yftan@aikonchem.com
Credit Asia Chemical Co., Ltd.
Tel
+86 (21) 61124340
More
Less

Imidazo[1,5-a]pyridin-8(5H)-one, 6,7-dihydro- (9CI)(426219-51-4)Related Product Information